We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Delivering Portable Chest Radiography Through Glass (TG-CXR) Reduces COVID-19 Infection Risk in Hospitals

By HospiMedica International staff writers
Posted on 20 Apr 2021
Illustration
Illustration
A study to understand the cost and benefit of adopting portable chest radiography through glass (TG-CXR) at a tertiary care centre during the COVID-19 pandemic has found the novel technique to be particularly beneficial.

A team of two technologists at the Department of Radiology, St. Michael's Hospital, University of Toronto (Toronto, ON, Canada) were trained on the TG-CXR method which has the benefit of allowing one technologist to stay outside of the patient room while operating the portable radiography machine, thus reducing PPE use, decreasing the frequency of radiography machine sanitization and reducing their exposure to potentially infectious patients.

The cost of implementing the technique during the current COVID-19 pandemic was obtained from the department's operational database. The direct cost of routinely used PPE and sanitization materials and the cost of the time taken by the technologists to clean the machine was used to form a quantitative picture of the benefit associated with TG-CXR technique.

The technologists were trained on the TG-CXR method during a 15 minute shift change briefing. This translated to a one-time cost of USD 424.88. There was an average reduction of portable radiography machine downtime of four minutes and 48 seconds per study. The benefit of adopting the TG-CXR technique was USD 9.87 per patient imaged, resulting in a projected net cost savings of USD 51,451.84 per annum. Thus, the study concluded that adoption of the TG-CXR technique during the COVID-19 pandemic involves a minimal one-time cost, but can result in a significant benefit over the year.

"We hope that our findings would encourage policy-makers to implement TG-CXR technique at their institutions when and where possible," the study concluded.

Related Links:
University of Toronto

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Emergency Ventilator
Shangrila935

Channels

Critical Care

view channel
Image: Preprocessing, building, and applying multimodal AI in cardiology (Xin-yue Yang et al., Precision Clinical Medicine (2025). DOI: 10.1093/pcmedi/pbaf016)

Multimodal AI to Revolutionize Cardiovascular Disease Diagnosis and Treatment

Cardiovascular diseases remain the leading cause of death worldwide, and while artificial intelligence (AI) has shown promise in their diagnosis and management, most existing systems rely on a single data... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more